| # | Drug | Count |
|---|---|---|
| 0 | FLUOXETINE | 6 |
| 1 | FLUOXETINE HYDROCHLORIDE | 6 |
| 2 | FOLIC ACID | 6 |
| 3 | ASFOTASE ALFA | 2 |
| 4 | CYCLOPHOSPHAMIDE | 2 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 7 | ETOPOSIDE | 2 |
| 8 | LEFLUNOMIDE | 2 |
| 9 | USTEKINUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 1 | THIOGUANINE | 1 | 0.0005 |
| 2 | ASFOTASE ALFA | 2 | 0.0002 |
| 3 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | THIOTEPA | 1 | 0.0001 |
| 5 | FLUOXETINE HYDROCHLORIDE | 6 | 0.0000 |
| 6 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 1 | 0.0000 |
| 7 | MELPHALAN HYDROCHLORIDE | 1 | 0.0000 |
| 8 | ETOPOSIDE | 2 | 0.0000 |
| 9 | FOLIC ACID | 6 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vitamin B12 [EPC] | 6 |
| 1 | Vitamin C [EPC] | 6 |
| 2 | Vitamin D [EPC] | 6 |
| 3 | Alkylating Drug [EPC] | 2 |
| 4 | Antirheumatic Agent [EPC] | 2 |
| 5 | Interleukin-12 Antagonist [EPC] | 2 |
| 6 | Interleukin-23 Antagonist [EPC] | 2 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 2 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 |
| 9 | Topoisomerase Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 1 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Vitamin D [EPC] | 6 | 0.0000 |
| 3 | Interleukin-12 Antagonist [EPC] | 2 | 0.0000 |
| 4 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 5 | Antirheumatic Agent [EPC] | 2 | 0.0000 |
| 6 | Vitamin B12 [EPC] | 6 | 0.0000 |
| 7 | Vitamin C [EPC] | 6 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |